Logo image of AKE.PA

ARKEMA (AKE.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:AKE - FR0010313833 - Common Stock

52.15 EUR
-0.05 (-0.1%)
Last: 12/31/2025, 7:00:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to AKE. AKE was compared to 68 industry peers in the Chemicals industry. AKE has an average financial health and profitability rating. AKE has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

AKE had positive earnings in the past year.
AKE had a positive operating cash flow in the past year.
Each year in the past 5 years AKE has been profitable.
Each year in the past 5 years AKE had a positive operating cash flow.
AKE.PA Yearly Net Income VS EBIT VS OCF VS FCFAKE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

1.2 Ratios

The Return On Assets of AKE (1.51%) is comparable to the rest of the industry.
With a Return On Equity value of 2.90%, AKE perfoms like the industry average, outperforming 52.94% of the companies in the same industry.
AKE's Return On Invested Capital of 3.44% is in line compared to the rest of the industry. AKE outperforms 47.06% of its industry peers.
The Average Return On Invested Capital over the past 3 years for AKE is in line with the industry average of 7.01%.
Industry RankSector Rank
ROA 1.51%
ROE 2.9%
ROIC 3.44%
ROA(3y)4.01%
ROA(5y)5.07%
ROE(3y)7.69%
ROE(5y)9.89%
ROIC(3y)5.57%
ROIC(5y)5.74%
AKE.PA Yearly ROA, ROE, ROICAKE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

With a Profit Margin value of 2.22%, AKE perfoms like the industry average, outperforming 54.41% of the companies in the same industry.
AKE's Profit Margin has declined in the last couple of years.
The Operating Margin of AKE (6.35%) is comparable to the rest of the industry.
AKE's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 19.02%, AKE is not doing good in the industry: 76.47% of the companies in the same industry are doing better.
AKE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.35%
PM (TTM) 2.22%
GM 19.02%
OM growth 3Y-14.88%
OM growth 5Y-6.39%
PM growth 3Y-36.12%
PM growth 5Y-8.82%
GM growth 3Y-3.36%
GM growth 5Y-1.36%
AKE.PA Yearly Profit, Operating, Gross MarginsAKE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so AKE is still creating some value.
AKE has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, AKE has less shares outstanding
Compared to 1 year ago, AKE has a worse debt to assets ratio.
AKE.PA Yearly Shares OutstandingAKE.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
AKE.PA Yearly Total Debt VS Total AssetsAKE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

AKE has an Altman-Z score of 1.87. This is not the best score and indicates that AKE is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 1.87, AKE is not doing good in the industry: 73.53% of the companies in the same industry are doing better.
AKE has a debt to FCF ratio of 16.70. This is a negative value and a sign of low solvency as AKE would need 16.70 years to pay back of all of its debts.
AKE has a Debt to FCF ratio (16.70) which is in line with its industry peers.
A Debt/Equity ratio of 0.50 indicates that AKE is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.50, AKE perfoms like the industry average, outperforming 41.18% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 16.7
Altman-Z 1.87
ROIC/WACC0.72
WACC4.76%
AKE.PA Yearly LT Debt VS Equity VS FCFAKE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

AKE has a Current Ratio of 2.73. This indicates that AKE is financially healthy and has no problem in meeting its short term obligations.
AKE's Current ratio of 2.73 is amongst the best of the industry. AKE outperforms 80.88% of its industry peers.
AKE has a Quick Ratio of 1.92. This is a normal value and indicates that AKE is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Quick ratio value of 1.92, AKE belongs to the best of the industry, outperforming 83.82% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.73
Quick Ratio 1.92
AKE.PA Yearly Current Assets VS Current LiabilitesAKE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2

3. Growth

3.1 Past

AKE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -38.40%.
Measured over the past 5 years, AKE shows a small growth in Earnings Per Share. The EPS has been growing by 0.10% on average per year.
AKE shows a small growth in Revenue. In the last year, the Revenue has grown by 0.32%.
AKE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.78% yearly.
EPS 1Y (TTM)-38.4%
EPS 3Y-11.49%
EPS 5Y0.1%
EPS Q2Q%-54.67%
Revenue 1Y (TTM)0.32%
Revenue growth 3Y0.09%
Revenue growth 5Y1.78%
Sales Q2Q%-8.65%

3.2 Future

AKE is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -2.13% yearly.
The Revenue is expected to grow by 1.37% on average over the next years.
EPS Next Y-42.01%
EPS Next 2Y-19.17%
EPS Next 3Y-8.39%
EPS Next 5Y-2.13%
Revenue Next Year-5.26%
Revenue Next 2Y-2.07%
Revenue Next 3Y-0.23%
Revenue Next 5Y1.37%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AKE.PA Yearly Revenue VS EstimatesAKE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B 10B
AKE.PA Yearly EPS VS EstimatesAKE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 10.13 indicates a reasonable valuation of AKE.
91.18% of the companies in the same industry are more expensive than AKE, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of AKE to the average of the S&P500 Index (26.51), we can say AKE is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 9.72, the valuation of AKE can be described as reasonable.
91.18% of the companies in the same industry are more expensive than AKE, based on the Price/Forward Earnings ratio.
AKE's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.13.
Industry RankSector Rank
PE 10.13
Fwd PE 9.72
AKE.PA Price Earnings VS Forward Price EarningsAKE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

94.12% of the companies in the same industry are more expensive than AKE, based on the Enterprise Value to EBITDA ratio.
AKE's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. AKE is cheaper than 79.41% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.47
EV/EBITDA 4.48
AKE.PA Per share dataAKE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

A cheap valuation may be justified as AKE's earnings are expected to decrease with -8.39% in the coming years.
PEG (NY)N/A
PEG (5Y)103.62
EPS Next 2Y-19.17%
EPS Next 3Y-8.39%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.06%, AKE is a good candidate for dividend investing.
AKE's Dividend Yield is rather good when compared to the industry average which is at 2.51. AKE pays more dividend than 94.12% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.00, AKE pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.06%

5.2 History

On average, the dividend of AKE grows each year by 6.80%, which is quite nice.
Dividend Growth(5Y)6.8%
Div Incr Years4
Div Non Decr Years4
AKE.PA Yearly Dividends per shareAKE.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

129.52% of the earnings are spent on dividend by AKE. This is not a sustainable payout ratio.
AKE's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP129.52%
EPS Next 2Y-19.17%
EPS Next 3Y-8.39%
AKE.PA Yearly Income VS Free CF VS DividendAKE.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
AKE.PA Dividend Payout.AKE.PA Dividend Payout, showing the Payout Ratio.AKE.PA Dividend Payout.PayoutRetained Earnings

ARKEMA

EPA:AKE (12/31/2025, 7:00:00 PM)

52.15

-0.05 (-0.1%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-07 2025-11-07/bmo
Earnings (Next)02-25 2026-02-25/amc
Inst Owners61.12%
Inst Owner ChangeN/A
Ins Owners0.58%
Ins Owner ChangeN/A
Market Cap3.97B
Revenue(TTM)9.54B
Net Income(TTM)210.00M
Analysts71.43
Price Target63.94 (22.61%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.06%
Yearly Dividend3.46
Dividend Growth(5Y)6.8%
DP129.52%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-7.64%
Min EPS beat(2)-8.67%
Max EPS beat(2)-6.61%
EPS beat(4)0
Avg EPS beat(4)-8.86%
Min EPS beat(4)-18.44%
Max EPS beat(4)-1.73%
EPS beat(8)3
Avg EPS beat(8)-4.83%
EPS beat(12)7
Avg EPS beat(12)1.09%
EPS beat(16)11
Avg EPS beat(16)10.55%
Revenue beat(2)0
Avg Revenue beat(2)-0.69%
Min Revenue beat(2)-0.92%
Max Revenue beat(2)-0.46%
Revenue beat(4)0
Avg Revenue beat(4)-1.13%
Min Revenue beat(4)-2.56%
Max Revenue beat(4)-0.46%
Revenue beat(8)2
Avg Revenue beat(8)-0.53%
Revenue beat(12)4
Avg Revenue beat(12)-0.93%
Revenue beat(16)8
Avg Revenue beat(16)0.76%
PT rev (1m)-3.09%
PT rev (3m)-18.52%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-28.26%
EPS NY rev (1m)-9.51%
EPS NY rev (3m)-15.94%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.74%
Revenue NY rev (1m)-0.44%
Revenue NY rev (3m)-2.33%
Valuation
Industry RankSector Rank
PE 10.13
Fwd PE 9.72
P/S 0.42
P/FCF 17.47
P/OCF 3.9
P/B 0.55
P/tB 1.85
EV/EBITDA 4.48
EPS(TTM)5.15
EY9.88%
EPS(NY)5.36
Fwd EY10.29%
FCF(TTM)2.98
FCFY5.72%
OCF(TTM)13.36
OCFY25.61%
SpS124.15
BVpS95.11
TBVpS28.16
PEG (NY)N/A
PEG (5Y)103.62
Graham Number104.98
Profitability
Industry RankSector Rank
ROA 1.51%
ROE 2.9%
ROCE 4.88%
ROIC 3.44%
ROICexc 3.86%
ROICexgc 7.22%
OM 6.35%
PM (TTM) 2.22%
GM 19.02%
FCFM 2.4%
ROA(3y)4.01%
ROA(5y)5.07%
ROE(3y)7.69%
ROE(5y)9.89%
ROIC(3y)5.57%
ROIC(5y)5.74%
ROICexc(3y)6.56%
ROICexc(5y)6.98%
ROICexgc(3y)13.06%
ROICexgc(5y)13.27%
ROCE(3y)8.13%
ROCE(5y)8.28%
ROICexgc growth 3Y-19.33%
ROICexgc growth 5Y-9.22%
ROICexc growth 3Y-22.98%
ROICexc growth 5Y-11.22%
OM growth 3Y-14.88%
OM growth 5Y-6.39%
PM growth 3Y-36.12%
PM growth 5Y-8.82%
GM growth 3Y-3.36%
GM growth 5Y-1.36%
F-Score5
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 16.7
Debt/EBITDA 2.56
Cap/Depr 95.75%
Cap/Sales 8.36%
Interest Coverage 17.14
Cash Conversion 71.35%
Profit Quality 108.1%
Current Ratio 2.73
Quick Ratio 1.92
Altman-Z 1.87
F-Score5
WACC4.76%
ROIC/WACC0.72
Cap/Depr(3y)97.52%
Cap/Depr(5y)93.37%
Cap/Sales(3y)7.14%
Cap/Sales(5y)7.42%
Profit Quality(3y)111.66%
Profit Quality(5y)102.9%
High Growth Momentum
Growth
EPS 1Y (TTM)-38.4%
EPS 3Y-11.49%
EPS 5Y0.1%
EPS Q2Q%-54.67%
EPS Next Y-42.01%
EPS Next 2Y-19.17%
EPS Next 3Y-8.39%
EPS Next 5Y-2.13%
Revenue 1Y (TTM)0.32%
Revenue growth 3Y0.09%
Revenue growth 5Y1.78%
Sales Q2Q%-8.65%
Revenue Next Year-5.26%
Revenue Next 2Y-2.07%
Revenue Next 3Y-0.23%
Revenue Next 5Y1.37%
EBIT growth 1Y-21.16%
EBIT growth 3Y-14.81%
EBIT growth 5Y-4.73%
EBIT Next Year42.37%
EBIT Next 3Y16.8%
EBIT Next 5Y12.34%
FCF growth 1Y-64.53%
FCF growth 3Y33.3%
FCF growth 5Y-10.84%
OCF growth 1Y-26.48%
OCF growth 3Y7%
OCF growth 5Y-2.92%

ARKEMA / AKE.PA FAQ

What is the fundamental rating for AKE stock?

ChartMill assigns a fundamental rating of 4 / 10 to AKE.PA.


Can you provide the valuation status for ARKEMA?

ChartMill assigns a valuation rating of 6 / 10 to ARKEMA (AKE.PA). This can be considered as Fairly Valued.


How profitable is ARKEMA (AKE.PA) stock?

ARKEMA (AKE.PA) has a profitability rating of 4 / 10.


Can you provide the financial health for AKE stock?

The financial health rating of ARKEMA (AKE.PA) is 5 / 10.


Is the dividend of ARKEMA sustainable?

The dividend rating of ARKEMA (AKE.PA) is 6 / 10 and the dividend payout ratio is 129.52%.